Friday, 27 December 2013 17:02

Topamax: Mass Tort Update

Written by Law Offices Of Gary Green

Janssen Pharmaceuticals was recently ordered to pay more than $10 million to the parents of a child who suffered birth defects due to the epilepsy drug Topamax. The Philadelphia jury found that the company, a unit of Johnson & Johnson, didn’t sufficiently warn doctors about the risk of birth defects stemming from use of the drug.

The North American Antiepileptic Drug Pregnancy Registry found a link between an increased risk of cleft lips and cleft palates to infants who are exposed to Topamax and its generic versions during the early months of pregnancy. The FDA has issued a warning that Topamax increases the risk of certain congenital defects – risks that Janssen Pharmaceuticals knew about years before the drug was prescribed to patients.

If you or someone you know has suffered as a result of the antiepileptic drug Topamax, contact Law Offices of Gary Green today to discuss your legal options without obligation. Call us toll-free at 1-888-4GARYGREEN or email us at

Tuesday, 17 December 2013 15:57

NuvaRing Lawsuits on the Rise

Written by Law Offices Of Gary Green

NuvaRing is a prescription contraceptive device from Merck Pharmaceuticals that has recently come under fire for associated health risks and side effects. Lawsuits filed against the manufacturers and marketers of NuvaRing allege that women and their doctors were not adequately warned of the potentially life-threatening side effects associated with the device, including blood clots and deep vein thrombosis.

Like most birth control medications, NuvaRing releases hormones, including estrogen and progestin, that prevent pregnancy. But NuvaRing also uses a third-generation hormone called desogestrel that makes blood clots 2.5 to 3 times more likely than earlier hormone-based contraceptives. In fact, a 2012 study published in British Medical Journal found that vaginal rings increase the risk of VTE – venous thromboembolism – by 90 percent when compared to oral contraceptives. VTEs, or blood clots that block a vein, most often occur in the leg, but they can break away and travel to the lungs and become a life-threatening pulmonary embolism.

If you or someone you love has suffered a blood clot, pulmonary embolism, deep vein thrombosis, stroke, or other health ailment as a result of taking NuvaRing, contact Law Offices of Gary Green today to discuss your legal options without obligation. Call us toll-free at 1-888-4GARYGREEN or email us at

Wednesday, 24 October 2012 20:53

Drug & Medical Device Claims

Written by Law Offices Of Gary Green

Law Offices of Gary Green has offices located in Little Rock, Arkansas, and Memphis, Tennessee. Our lawyers are familiar with the individual laws of each state, and practice in the following types of nursing home neglect and abuse law:

Thursday, 28 June 2012 12:49


Written by Law Offices Of Gary Green

Yasmin and its newer version, Yaz, are birth control pills manufactured by Bayer Healthcare. Their generic counterpart, Ocella, is produced by Barr Laboratories.

These once-a-day oral contraceptives contain drospirenone and ethinyl estradiol and were heavily marketed without adequate warnings about the serious and potentially life-threatening side effects. Users with pre-existing kidney or liver disease could be particularly susceptible to these safety concerns, yet the manufacturers of these drugs failed to provide adequate information and warnings to consumers and healthcare providers.

Although Yaz and Yasmin contain components used in birth control pills for years, the component drospirenone is exclusive to these drugs. Drospirenone has been linked to dehydration which can then lead to an increase in potassium. This potassium increase is known as hyperkalemia. Because of the direct connection between potassium levels and heart rhythm, any disturbance in potassium levels can be serious and dangerous.

Some side effects associated with the use of Yasmin, Yaz and Ocella include:

  • Blood clots and blood clot-related injuries
  • Strokes
  • Deep vein thrombosis
  • Pulmonary embolism
  • Heart attacks
  • Gallbladder injuries; gallbladder removal
  • Kidney stones
  • Kidney failure
  • Pancreatic cancer
  • Death

If you or someone you know suffered from blood clots, stroke, heart attack, deep vein thrombosis, gallbladder disease or death while using Yasmin, Yaz or Ocella, contact Law Offices of Gary Green toll free at 1-888-4GARYGREEN or send us an e-mail at to discuss your legal options without obligation.

Wednesday, 6 June 2012 12:54


Written by Law Offices Of Gary Green

Pradaxa (chemical name dabigatran), is manufactured by the privately held German company Boehringer Ingelheim and was approved for use in the United States in October, 2010. Pradaxa is used in patients with atrial fibrillation (dangerous irregular heartbeat) as an anticoagulant medicine that reduces the risk of blood clots forming in the body and causing a stroke. Atrial fibrillation mostly affects the elderly. Pradaxa is a direct thrombin inhibitor meant to replace warfarin. One of the main problems with Pradaxa is in the event of traumatic hemorrhage, there are currently no effective reversal agents. The Journal of Neurosurgery cites the case of an 83 year old man that was hospitalized following a routine fall. Initial CT scans revealed small, superficial area of hemorrhage in his brain. A repeat CT scan two hours later showed a massive brain hemorrhage that resulted in the patient’s death.

If you or someone you know has suffered as a result of Pradaxa, contact Law Offices of Gary Green toll free at 1-888-4GARYGREEN or send us an e-mail at

Wednesday, 6 June 2012 12:53

Transvaginal Mesh

Written by Law Offices Of Gary Green

Transvaginal mesh is used to treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI).

POP occurs when a pelvic organ drops from its normal position and pushes against the wall of the vagina. POP often occurs after childbirth or surgery when the muscles that hold the pelvic organs become weak or stretched. Thirty to fifty percent of women may experience POP. Two percent of women develop symptoms.

Between 2005 and 2010 almost 4000 cases involving complication were reported to the Food and Drug Administration (FDA).

Transvaginal mesh is manufactured by several different companies, including, but not limited to: Bard, Gynecare, American Medical Systems (AMS), Boston Scientific, Tyco, Covidian, Mentor, Johnson & Johnson and Ethicon. Complications associated with transvaginal mesh are not linked to a single brand. Complications include:

  • Erosion of the mesh through the vagina
  • Infection
  • Pain
  • Painful intercourse
  • Urinary problems
  • Recurrence of prolapse
  • Incontinence
  • Injury to surrounding organs

The most common complications occur within 10% of women within one year of surgery.

If you or someone you know has suffered as a result of transvaginal mesh, contact Law Offices of Gary Green toll free at 1-888-4GARYGREEN or send us an e-mail at

Wednesday, 22 February 2012 12:55


Written by Law Offices Of Gary Green

Finasteride is a competitive and specific inhibitor of Type II 5á-reductase, an intracellular enzyme that converts the androgen testosterone into DHT. (Dihydrotestosterone 5á-Dihydrotestosterone is an androgen or male sex hormone.) Finasteride has not been approved for use in women or children. Finasteride is produced by pharmaceutical giant Merck.

Propecia is the 1mg dose of Finasteride. Propecia is used to treat androgenetic alopecia, also known as male pattern baldness. Proscar is the 5mg dose of Finasteride. Proscar is used to treat Benign Prostatic Hyperplasia (BHP or enlarged prostate).

For more information, please visit

If you or someone you know has suffered from male breast cancer while using Finasteride (Propecia or Proscar), contact Law Offices of Gary Green toll free at 1-888-4GARYGREEN or send us an e-mail at

Thursday, 17 November 2011 12:56


Written by Law Offices Of Gary Green

Actos (pioglitazone) is manufactured by Takeda Pharmaceuticals and is a drug normally prescribed for the treatment of Type II diabetes. On June 16, 2011, the FDA issued a new warning citing increased risk of bladder cancer in patients taking Actos for more than a year. In September, 2011 the FDA began a safety review of Actos after initial data from the manufacturer’s ongoing study indicated that the drug may increase the risk of bladder cancer. Two European countries have already banned the use of the drug. However, the FDA has not banned these medicines from being issued in the United States.

If you or someone you know suffered from bladder cancer while using Actos, contact Law Offices of Gary Green toll free at 1-888-4GARYGREEN or send us an e-mail at

Friday, 21 May 2010 22:41

Drug and Medical Device Claims

Written by Law Offices Of Gary Green

Please click on one of the following links for more information.


Friday, 21 May 2010 22:41


Written by Law Offices Of Gary Green

Gadolinium is an FDA approved contrast agent for MRI and MRA. Gadolinium provides greater contrast between normal tissue and abnormal tissue in the brain and body. It looks clear like water and is non-radioactive. After it is injected into a vein, Gadolinium accumulates in the abnormal tissue that may be affecting the body or head. Gadolinium causes these abnormal areas to become very bright (enhanced) on the MRI. This makes it very easy to see. Gadolinium is then rapidly cleared from the body by the kidneys.

On May 23, 2007—The FDA announced that it is asking manufacturers of gadolinium-based contrast agents to include a black box warning alerting patients to the risk of a potentially fatal disease NSF (Nephrogenic Systemic Fibrosis) or NFD (Nephrogenic Fibrosing Dermopathy).

It is a condition which involves hardening of the skin, resulting in varying degrees of immobility, can damage internal organs, and is sometimes fatal. It appears to affect only those persons with impaired renal function caused by kidney disease. NSF / NFD is resistant to treatment and can be very painful and debilitating. Most importantly, NSF / NFD is entirely preventable.

The following gadolinium-based agents are implicated by the warning:

  • Magnevist (gadopentetate dimeglumine)
  • Omniscan (gadodiamide)
  • OptiMARK (gadoversetamide)
  • MultiHance (gadobenate dimeglumine)
  • ProHance (gadoteridol)

The FDA has been aware of problems with gadolinium since at least June 2006, when the agency warned healthcare professionals about the risk of nephrogenic systemic fibrosis. A subsequent warning was issued in December 2006.

If you experience any of the symptoms of NSF / NFD after MRI (Magnetic Resonance Imaging) or MRA (Magnetic Resonance Angiogram), you should seek immediate medical attention and get tested for the disease. Symptoms include:

  • Tightening and swelling of the skin, typically starting with the legs, moving to the arms, and sometimes the trunk
  • Thickening of the skin around the joints, restricting movement
  • Skin which feels “woody” and has a texture similar to that of an orange peel
  • Red or dark patches of skin
  • Burning, itching, and/or sharp pains in affected areas
  • Fluctuating hypertension preceding the appearance of skin lesions
  • Symmetrical skin lesions, commonly on the ankles and thighs and between the wrists and upper arms
  • Muscle weakness
  • Deep bone pain in the hips and ribs
  • Calcification of soft tissues
  • Yellow plaques near the eyes

If you have kidney disease or impaired renal function you should always question having a MRI / MRA with contrast to make sure the contrast being used is not one of the ones listed above.  When asked if you are allergic to any medications you should say “Yes, Gadolinium!”

Currently, there are federal lawsuits pending in the United States against the drug manufacturers: Bayer Healthcare, Bracco, GE Healthcare and Mallinckrodt due to the possibility that they have not properly informed patients and doctors regarding the dangerous side effects of these drugs.

Over 250 federal lawsuits have been consolidated in a Multidistrict Litigation (MDL) in the Northern District of Ohio, and at least another 104 cases have been filed in various state courts. The purpose of the MDL is to prevent inconsistent pretrial rulings, avoid duplicity and serve the convenience of the parties, witnesses and the Court. Under the MDL rules, if the cases do not settle or resolve during pretrial, they will be returned to the court in which they were filed.

Attorneys representing persons suffering from NSF have been pushing for aggressive scheduling deadlines to move the cases quickly to trial or settlement, as most of the people are very sick and many may not survive a lengthy trial.

If you have been diagnosed with NSF or NFD you should contact  Law Offices of Gary Green toll free at 1-888-442-7947 or send us an e-mail at to discuss your legal options without obligation.